Article Details

AstraZeneca's anti-diabetic drug receives CDSCO approval for patients with chronic kidney ...

Retrieved on: 2022-11-29 08:09:42

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's anti-diabetic drug receives CDSCO approval for patients with chronic kidney .... View article details on hiswai:

Excerpt

AstraZeneca's Dapagliflozin is an oral anti-diabetes drug which has shown increasing benefits in not only preventing heart failure but also in ...

Article found on: www.financialexpress.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up